Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$5.47M Buy
75,000
+10,000
+15% +$738K 1.65% 24
2024
Q2
$4.36M Sell
65,000
-85,000
-57% -$3.3M 1.36% 28
2024
Q1
$4.07M Buy
+150,000
New +$4.2M 1.13% 29
2020
Q1
Sell
-200,000
Closed -$4.78M 57
2019
Q4
$4.78M Buy
+200,000
New +$4.07M 0.91% 36
2018
Q4
Sell
-26,000
Closed -$526K 51
2018
Q3
$526K Buy
+26,000
New +$587K 0.11% 52
2017
Q4
Sell
-324,400
Closed -$10.1M 59
2017
Q3
$10.1M Sell
324,400
-150,600
-32% -$2.87M 2.15% 13
2017
Q2
$8.15M Buy
+475,000
New +$8.11M 1.69% 19
2014
Q3
Sell
-200,000
Closed -$4M 79
2014
Q2
$4M Buy
200,000
+65,000
+48% +$963K 2.82% 12
2014
Q1
$2.57M Sell
135,000
-65,000
-33% -$1.24M 1.53% 22
2013
Q4
$3.4M Buy
+200,000
New +$3.06M 2.09% 17

Other funds holding INSM

Ghost Tree Capital's INSM Position: Q3 2024 in Review

Ghost Tree Capital increased its Insmed (INSM) stake by 15% in Q3 2024, buying an estimated $738K and bringing the position to 75,000 shares worth $5.47M. The position accounts for 1.65% of the portfolio, ranked #24.

Ghost Tree Capital first reported a position in INSM in Q4 2013 and has held it in 10 quarters since. The position peaked at $10.1M in Q3 2017. 413 funds tracked by Wall St. Rank hold INSM as of Q3 2024.

  • Ghost Tree Capital held 75,000 shares of Insmed worth $5.47M as of Q3 2024.
  • Ghost Tree Capital bought 10,000 Insmed shares in Q3 2024, an estimated $738K.
  • Insmed made up 1.65% of Ghost Tree Capital's portfolio in Q3 2024, its #24 holding.
  • Ghost Tree Capital first reported a position in Insmed in Q4 2013 and has held it in 10 quarters since.
  • Ghost Tree Capital's Insmed position peaked at $10.1M in Q3 2017.
  • 413 funds tracked by Wall St. Rank held Insmed as of Q3 2024.

Based on Ghost Tree Capital's 13F filing for Q3 2024, filed 14 Nov 2024.